Summary
- Current Price
- As of today, FOLD price is $14.31, down -0.14% on
- Current Price All-Time High
- FOLD price is currently -43.64% below its historical high of $25.39 set on
- Market Cap
- FOLD current market cap is $4B, up +55.16% over the past 365 days
- PE Ratio
- FOLD PE ratio is unknown
- Revenue
- FOLD current annual revenue is $528.30M, up +32.29% year-over-year
- Next Earnings
- The next earnings release for FOLD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amicus Therapeutics, Inc. |
| Ticker | NASDAQ: FOLD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amicusrx.com |
| Employees | 499 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.31 | |
| Price, 1D Change | -0.14% | |
| $4B | ||
| - | ||
| - | ||
| 0.65 | ||
| $528M | ||
| Revenue, 1Y Change | +32.29% | |
| -$0.18 | ||
| EPS, 1Y Change | +64.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.18 | ||
| EPS Estimate | $0.39 | |
| EPS Est. Change | +313.24% | |
| $528.30M | ||
| Revenue Estimate | $634.00M | |
| Revenue Est. Change | +20.01% | |
| Current Price | $14.31 | |
| Price Target | - | $14.50 |
| Price Tgt. Change | - | +1.33% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.45 | -$0.51 | -14.13% | |
| $0.24 | -$0.18 | -178.19% | |
| $0.39 | N/A | +313.24% | |
| $0.65 | N/A | +450.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $398.67M | $399.36M | +0.17% | |
| $527.02M | $528.30M | +0.24% | |
| $634.00M | N/A | +20.01% | |
| $749.52M | N/A | +41.88% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.31 | |
| $8.85 | ||
| SMA 200 vs Price | -38.13% | |
| $13.32 | ||
| SMA 50 vs Price | -6.92% | |
| 0.65 | ||
| $0.08 | ||
| 77.20 | ||
| 1.46% | ||
| 49.38% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $528.30M | ||
| -$0.18 | ||
| $466.81M | ||
| 88.36% | ||
| $34.06M | ||
| 6.45% | ||
| -$56.11M | ||
| -10.62% | ||
| $42.61M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.29 | ||
| 3.39 | ||
| 2.60 | ||
| - | ||
| 4 | ||
| 0.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.50 | ||
| 19.48 | ||
| 110.83 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $194.05M | ||
| $249.95M | ||
| $785.03M | ||
| $504.74M | ||
| $590.99M | ||
| $148.70M | ||
| $443.64M | ||
| $8.46M | ||
| $12.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $584.40M | ||
| $432.74M | ||
| $61.49M | ||
| $0.00 | ||
| $8.55M | ||
| $0.00 | ||
| $27.35M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$33.89M | ||
| -$560.00K | ||
| $5.12M | ||
| $3.55M | ||
| -$37.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | → | |
| Leerink Partners | → | |
| Citigroup | → | |
| Needham | → | |
| Cantor Fitzgerald | → | |
| Citigroup | ||
| JP Morgan | → | |
| Goldman Sachs | → | |
| Needham | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with FOLD
FAQ
What is the ticker symbol for Amicus Therapeutics, Inc.?
The ticker symbol for Amicus Therapeutics, Inc. is NASDAQ:FOLD
Does Amicus Therapeutics, Inc. pay dividends?
No, Amicus Therapeutics, Inc. does not pay dividends
What sector is Amicus Therapeutics, Inc. in?
Amicus Therapeutics, Inc. is in the Healthcare sector
What industry is Amicus Therapeutics, Inc. in?
Amicus Therapeutics, Inc. is in the Biotechnology industry
What country is Amicus Therapeutics, Inc. based in?
Amicus Therapeutics, Inc. is headquartered in United States
When did Amicus Therapeutics, Inc. go public?
Amicus Therapeutics, Inc. initial public offering (IPO) was on May 31, 2007
Is Amicus Therapeutics, Inc. in the S&P 500?
No, Amicus Therapeutics, Inc. is not included in the S&P 500 index
Is Amicus Therapeutics, Inc. in the NASDAQ 100?
No, Amicus Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Amicus Therapeutics, Inc. in the Dow Jones?
No, Amicus Therapeutics, Inc. is not included in the Dow Jones index
When was Amicus Therapeutics, Inc. last earnings report?
Amicus Therapeutics, Inc.'s most recent earnings report was on November 4, 2025
When does Amicus Therapeutics, Inc. report earnings?
The next expected earnings date for Amicus Therapeutics, Inc. is February 18, 2026
Data Sources & References
- FOLD Official Website amicusrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1178879/000117887925000015/0001178879-25-000015-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178879/000117887925000003/0001178879-25-000003-index.htm
- FOLD Profile on Yahoo Finance finance.yahoo.com/quote/FOLD
- FOLD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fold